Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Research (NRC) Shares Outstanding (Diluted Average) (2016 - 2025)

National Research's Shares Outstanding (Diluted Average) history spans 16 years, with the latest figure at $22.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 5.67% year-over-year to $22.4 million; the TTM value through Dec 2025 reached $22.4 million, down 5.67%, while the annual FY2025 figure was $22.4 million, 5.67% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $22.4 million at National Research, down from $23.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $25.6 million in Q4 2021 and bottomed at $22.4 million in Q4 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $24.7 million (2023), against an average of $24.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) decreased 0.22% in 2021 before it dropped 5.67% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $25.6 million in 2021, then fell by 2.29% to $25.1 million in 2022, then fell by 1.51% to $24.7 million in 2023, then fell by 3.77% to $23.7 million in 2024, then decreased by 5.67% to $22.4 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Shares Outstanding (Diluted Average) are $22.4 million (Q4 2025), $23.7 million (Q4 2024), and $24.7 million (Q4 2023).